cancer immunotherapy
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
CellVec enters strategic partnership with Peter MacCallum Cancer Centre
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.